UroPharma is a MedTech company focused on global commercialization of innovative and potentially disruptive therapeutic technology to treat a broad range of urinary tract disorders. UroPharma's patented drug-delivery device, dtb-instilla™ minimizes the negative side effects of conventional systemic forms of treatment by dispensing the medications directly into the bladder, direct-to-bladder (dtb) therapy.